The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
13 December 2016: Abingdon, UK - AMSBIO has introduced the MitoXpress® Xtra Fatty Acid Oxidation (FAO) kit to facilitate the convenient measurement of FAO-driven respiration.
Fatty acid oxidation is the primary metabolic pathway in a variety of tissues, which is particularly important during periods of glucose deprivation. In organs such as liver and skeletal muscle, FAO can provide over 75% of cellular ATP while in cardiac tissue it can be responsible for up to 90% of cellular energy requirements. FAO is today also acknowledged as a key factor in cancer metabolism and is also implicated in drug-induced microsteatosis.
The MitoXpress® Xtra FAO kit is designed for use with the MitoXpress® Xtra HS - Oxygen Consumption Assay and contains the 18C unsaturated fatty acid Oleate as substrate, supplied as a 2:1 BSA conjugate. The kit also contains a buffer tablet and L-Carnitine for convenient preparation of measurement media and two FAO modulators, Etomoxir and FCCP.
AMSBIO's MitoXpress® Xtra reagents offer a convenient fluorescence plate reader-based, high throughput approach to the direct real-time analysis of mitochondrial oxygen consumption. The easy to use MitoXpress® Xtra FAO kit provides a direct measure of the primary pathway for the degradation of fatty acids - mitochondrial fatty acid ß oxidation.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.